Outcomes of Roux-en-Y gastric bypass versus sleeve gastrectomy in super-super- obese patients (BMI ≥60 kg/m2): 6-year follow-up at a single university Konstantinos Arapis, M.D., Ph.D., Nicoletta Macrina, M.D., Diana Kadouch, M.D., Lara Ribeiro Parenti, M.D., Jean Pierrre Marmuse, M.D., Boris Hansel, M.D., Ph.D. Surgery for Obesity and Related Diseases Volume 15, Issue 1, Pages 23-33 (January 2019) DOI: 10.1016/j.soard.2018.09.487 Copyright © 2018 American Society for Bariatric Surgery Terms and Conditions
Fig. 1 Body mass index (BMI) and percent of total weight loss (TWL%) at each interval up to 6 years for the sleeve gastrectomy and gastric bypass groups. m: months. Surgery for Obesity and Related Diseases 2019 15, 23-33DOI: (10.1016/j.soard.2018.09.487) Copyright © 2018 American Society for Bariatric Surgery Terms and Conditions
Fig. 2 Change in BMI (ΔBMI) and in percent excess weight loss (EWL%) at each interval up to 6 years for the sleeve gastrectomy and gastric bypass groups. *P ≤ .005. Surgery for Obesity and Related Diseases 2019 15, 23-33DOI: (10.1016/j.soard.2018.09.487) Copyright © 2018 American Society for Bariatric Surgery Terms and Conditions
Fig. 3 Diabetes, hypertension, obstructive sleep apnea, and gastroesophageal reflux disease resolution after 6 years after sleeve gastrectomy versus gastric bypass groups. Error bars represent the 95% confidence interval. *Statistically significant. Surgery for Obesity and Related Diseases 2019 15, 23-33DOI: (10.1016/j.soard.2018.09.487) Copyright © 2018 American Society for Bariatric Surgery Terms and Conditions